NCT03511794View on ClinicalTrials.gov

Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

April 13, 2018

Primary Completion Date

June 1, 2021

Study Completion Date

February 2, 2022

Conditions
Hepatitis B
Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT03511794 - Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant | Biotech Hunter | Biotech Hunter